The influence of the impact of biotechnological radioprotective drugs on the antitumor effect of experimental radiation therapy

Exposure to ionizing radiation during antitumor radiotherapy can cause undesirable side effects. This is damage to healthy tissues and organs. The use of radioprotective drugs can provide protection for normal cells, but there are risks of their negative impact on the antitumor effect of radiotherapy. The aim of the work is to study the possibility of using promising biotechnological radioprotective drugs to reduce the side effects of antitumor radiotherapy. Material and methods . The study was performed on model of Ehrlich’s carcinoma in BALB/c mice with experimental radiation treatment (4 Gy X-ray). Biotechnological products, developed by Russian specialists, were administered to mice before irradiation on the 12th day after the tumor was transplanted. Chitin-glucan complex extracted from Pleurotus ostreatus was administered at a dose of 500 mg/kg intragastrically, recombinant flagellin at a dose of 1 mg/kg intraperitoneally. The volume of tumor nodules was assessed at different time points during the experiment, the degree of tumor growth inhibition was calculated, and the spread of the tumor into nearby tissues was recorded. Results and discussion. The absence of stimulation of tumor growth during the use of drugs has been established. The drugs did not reduce the inhibition of Ehrlich tumor growth in mice caused by experimental X-ray treatment. In some periods of the experiment, mice with combination therapy showed a tendency to increase the effectiveness of radiation treatment by 4–6 %. The use of recombinant flagellin led to a decrease in the number of animals with a total spread of Ehrlich’s carcinoma. When using the mushroom chitin-glucan complex, there was a tendency to decrease the value of the integral dissemination score compared to control. Conclusions. It was shown that the chitin-glucan complex from the Pleurotus ostreatus and the deimmunized recombinant flagellin did not have a negative effect on the antitumor effect of radiation exposure. The possibility of their use as a means of accompanying radiotherapy of tumors has been experimentally confirmed.

Authors

Institutions

Publication Details

Journal
Сибирский научный медицинский журнал
Published
2025-05-06
DOI
https://doi.org/10.18699/ssmj20250211
Primary Topic
Effects of Radiation Exposure
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The influence of the impact of biotechnological radioprotective drugs on the antitumor effect of experimental radiation therapy

Natalia V. Aksenova, Г. А. Софронов, Elena D. Ermakova, Elena V. Murzina et al.
Сибирский научный медицинский журнал
Effects of Radiation Exposure
article

The influence of the impact of biotechnological radioprotective drugs on the antitumor effect of experimental radiation therapy

Natalia V. Aksenova, Г. А. Софронов, Elena D. Ermakova, Elena V. Murzina, Elena I. Fedoros, А. С. Симбирцев, E. V. Vorobeychikov
article en

Abstract

Exposure to ionizing radiation during antitumor radiotherapy can cause undesirable side effects. This is damage to healthy tissues and organs. The use of radioprotective drugs can provide protection for normal cells, but there are risks of their negative impact on the antitumor effect of radiotherapy. The aim of the work is to study the possibility of using promising biotechnological radioprotective drugs to reduce the side effects of antitumor radiotherapy. Material and methods . The study was performed on model of Ehrlich’s carcinoma in BALB/c mice with experimental radiation treatment (4 Gy X-ray). Biotechnological products, developed by Russian specialists, were administered to mice before irradiation on the 12th day after the tumor was transplanted. Chitin-glucan complex extracted from Pleurotus ostreatus was administered at a dose of 500 mg/kg intragastrically, recombinant flagellin at a dose of 1 mg/kg intraperitoneally. The volume of tumor nodules was assessed at different time points during the experiment, the degree of tumor growth inhibition was calculated, and the spread of the tumor into nearby tissues was recorded. Results and discussion. The absence of stimulation of tumor growth during the use of drugs has been established. The drugs did not reduce the inhibition of Ehrlich tumor growth in mice caused by experimental X-ray treatment. In some periods of the experiment, mice with combination therapy showed a tendency to increase the effectiveness of radiation treatment by 4–6 %. The use of recombinant flagellin led to a decrease in the number of animals with a total spread of Ehrlich’s carcinoma. When using the mushroom chitin-glucan complex, there was a tendency to decrease the value of the integral dissemination score compared to control. Conclusions. It was shown that the chitin-glucan complex from the Pleurotus ostreatus and the deimmunized recombinant flagellin did not have a negative effect on the antitumor effect of radiation exposure. The possibility of their use as a means of accompanying radiotherapy of tumors has been experimentally confirmed.

Сибирский научный медицинский журналVol. 45(2)
S. M. Kirov Military Medical Academy (RU), State Research Institute of Highly Pure Biopreparations (RU)
Openalex Percentile: Top 85%
Effects of Radiation Exposure
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.